Pediacel®

BIOLOGICAL2 trials

Sponsors

MCM Vaccines B.V., Canadian Immunization Research Network

Conditions

Acute Lymphoblastic LeukemiaBacterial InfectionsNeisseria MeningitidisVirus Diseases

Phase 3

Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

CompletedNCT01839188

MCM Vaccines B.V.Bacterial Infections, Neisseria Meningitidis, Virus Diseases

Start: 2013-05-01End: 2014-03-19Updated: 2019-02-25

Phase 4

Vaccinating Children After Chemotherapy

CompletedNCT02447718

Canadian Immunization Research NetworkAcute Lymphoblastic Leukemia

Start: 2015-11-16End: 2018-03-05Updated: 2022-06-24

Related Papers

Waning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study

Clinical Infectious Diseases2020-02-1322 citations

Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).

2017-06-0213 citations